PubMed:1931834 JSONTXT

Annnotations TAB JSON ListView MergeView

    jnlpba-st-training

    {"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":47,"end":62},"obj":"DNA"},{"id":"T2","span":{"begin":88,"end":103},"obj":"protein"},{"id":"T3","span":{"begin":159,"end":176},"obj":"DNA"},{"id":"T4","span":{"begin":234,"end":252},"obj":"cell_line"},{"id":"T5","span":{"begin":253,"end":259},"obj":"cell_line"},{"id":"T6","span":{"begin":264,"end":270},"obj":"cell_line"},{"id":"T7","span":{"begin":429,"end":444},"obj":"DNA"},{"id":"T8","span":{"begin":457,"end":487},"obj":"DNA"},{"id":"T9","span":{"begin":543,"end":558},"obj":"protein"},{"id":"T10","span":{"begin":559,"end":565},"obj":"protein"},{"id":"T11","span":{"begin":602,"end":665},"obj":"protein"},{"id":"T12","span":{"begin":715,"end":729},"obj":"DNA"},{"id":"T13","span":{"begin":811,"end":825},"obj":"DNA"},{"id":"T14","span":{"begin":861,"end":867},"obj":"protein"},{"id":"T15","span":{"begin":900,"end":930},"obj":"protein"},{"id":"T16","span":{"begin":960,"end":979},"obj":"protein"},{"id":"T17","span":{"begin":989,"end":1004},"obj":"protein"},{"id":"T18","span":{"begin":1032,"end":1038},"obj":"protein"},{"id":"T19","span":{"begin":1044,"end":1055},"obj":"DNA"},{"id":"T20","span":{"begin":1092,"end":1098},"obj":"protein"},{"id":"T21","span":{"begin":1130,"end":1143},"obj":"DNA"},{"id":"T22","span":{"begin":1201,"end":1207},"obj":"protein"},{"id":"T23","span":{"begin":1222,"end":1233},"obj":"DNA"},{"id":"T24","span":{"begin":1287,"end":1293},"obj":"protein"},{"id":"T25","span":{"begin":1308,"end":1335},"obj":"DNA"},{"id":"T26","span":{"begin":1354,"end":1365},"obj":"DNA"},{"id":"T27","span":{"begin":1500,"end":1515},"obj":"DNA"},{"id":"T28","span":{"begin":1525,"end":1553},"obj":"DNA"},{"id":"T29","span":{"begin":1592,"end":1625},"obj":"protein"},{"id":"T30","span":{"begin":1680,"end":1695},"obj":"DNA"},{"id":"T31","span":{"begin":1711,"end":1717},"obj":"protein"},{"id":"T32","span":{"begin":1785,"end":1800},"obj":"DNA"},{"id":"T33","span":{"begin":1829,"end":1840},"obj":"DNA"}],"text":"Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.\nWe have conducted functional studies of the enhancer elements of human T-cell leukemia virus type I (HTLV-I) using the human T-cell lines Jurkat and MOLT 4, which are negative for HTLV-I, and MT-2 and TL-Mor, which carry the proviral genome of HTLV-I. Two distinct elements have been implicated in function of the HTLV-I enhancer. One is the 21-base-pair (bp) core element that is responsible for trans-activation by the HTLV-I trans-activator p40tax and that has the ability to bind to cyclic-AMP responsive element binding factor (CREB)-like factor(s). The other is a region interposed between the 21-bp elements. In this study we demonstrate that a subfragment (C26) in the region between the 21-bp elements is involved in trans-activation by p40tax, possibly through binding to an NF-kappa B-like nuclear factor or factors. Formation of the protein-DNA complex with the C26 subfragment was positively affected by p40tax. The C26 element conferred partial responsiveness to p40tax when linked to one copy of the 21-bp element that, by itself, showed little activation in response to p40tax. However, the C26 element alone, even when repeated, could not be activated by p40tax, unlike other NF-kappa B-binding elements. In contrast, the C26 element itself was profoundly activated upon stimulation with 12-O-tetradecanoylphorbol-13-acetate. These findings therefore suggest that the HTLV-I enhancer contains multiple functional elements, including binding sites for at least CREB- and NF-kappa B-like factors, which synergistically cooperate in activation of the HTLV-I enhancer in response to p40tax. Our results also demonstrate that TPA-dependent activation of the HTLV-I enhancer may be mediated through the C26 element."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S1","span":{"begin":0,"end":114},"obj":"Sentence"},{"id":"S2","span":{"begin":115,"end":366},"obj":"Sentence"},{"id":"S3","span":{"begin":367,"end":445},"obj":"Sentence"},{"id":"S4","span":{"begin":446,"end":669},"obj":"Sentence"},{"id":"S5","span":{"begin":670,"end":730},"obj":"Sentence"},{"id":"S6","span":{"begin":731,"end":942},"obj":"Sentence"},{"id":"S7","span":{"begin":943,"end":1039},"obj":"Sentence"},{"id":"S8","span":{"begin":1040,"end":1208},"obj":"Sentence"},{"id":"S9","span":{"begin":1209,"end":1336},"obj":"Sentence"},{"id":"S10","span":{"begin":1337,"end":1457},"obj":"Sentence"},{"id":"S11","span":{"begin":1458,"end":1718},"obj":"Sentence"},{"id":"S12","span":{"begin":1719,"end":1841},"obj":"Sentence"}],"text":"Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.\nWe have conducted functional studies of the enhancer elements of human T-cell leukemia virus type I (HTLV-I) using the human T-cell lines Jurkat and MOLT 4, which are negative for HTLV-I, and MT-2 and TL-Mor, which carry the proviral genome of HTLV-I. Two distinct elements have been implicated in function of the HTLV-I enhancer. One is the 21-base-pair (bp) core element that is responsible for trans-activation by the HTLV-I trans-activator p40tax and that has the ability to bind to cyclic-AMP responsive element binding factor (CREB)-like factor(s). The other is a region interposed between the 21-bp elements. In this study we demonstrate that a subfragment (C26) in the region between the 21-bp elements is involved in trans-activation by p40tax, possibly through binding to an NF-kappa B-like nuclear factor or factors. Formation of the protein-DNA complex with the C26 subfragment was positively affected by p40tax. The C26 element conferred partial responsiveness to p40tax when linked to one copy of the 21-bp element that, by itself, showed little activation in response to p40tax. However, the C26 element alone, even when repeated, could not be activated by p40tax, unlike other NF-kappa B-binding elements. In contrast, the C26 element itself was profoundly activated upon stimulation with 12-O-tetradecanoylphorbol-13-acetate. These findings therefore suggest that the HTLV-I enhancer contains multiple functional elements, including binding sites for at least CREB- and NF-kappa B-like factors, which synergistically cooperate in activation of the HTLV-I enhancer in response to p40tax. Our results also demonstrate that TPA-dependent activation of the HTLV-I enhancer may be mediated through the C26 element."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C2","span":{"begin":47,"end":53},"obj":"NP"},{"id":"C1","span":{"begin":43,"end":62},"obj":"NP"},{"id":"C3","span":{"begin":107,"end":113},"obj":"NP"},{"id":"C5","span":{"begin":180,"end":223},"obj":"NP"},{"id":"C4","span":{"begin":155,"end":223},"obj":"NP"},{"id":"C6","span":{"begin":230,"end":270},"obj":"NP"},{"id":"C7","span":{"begin":272,"end":277},"obj":"NP"},{"id":"C8","span":{"begin":295,"end":301},"obj":"NP"},{"id":"C9","span":{"begin":307,"end":322},"obj":"NP"},{"id":"C10","span":{"begin":324,"end":329},"obj":"NP"},{"id":"C11","span":{"begin":359,"end":365},"obj":"NP"},{"id":"C12","span":{"begin":367,"end":388},"obj":"NP"},{"id":"C14","span":{"begin":429,"end":435},"obj":"NP"},{"id":"C13","span":{"begin":425,"end":444},"obj":"NP"},{"id":"C15","span":{"begin":453,"end":487},"obj":"NP"},{"id":"C16","span":{"begin":488,"end":492},"obj":"NP"},{"id":"C17","span":{"begin":532,"end":565},"obj":"NP"},{"id":"C18","span":{"begin":570,"end":574},"obj":"NP"},{"id":"C19","span":{"begin":602,"end":668},"obj":"NP"},{"id":"C20","span":{"begin":670,"end":679},"obj":"NP"},{"id":"C22","span":{"begin":711,"end":729},"obj":"NP"},{"id":"C21","span":{"begin":683,"end":729},"obj":"NP"},{"id":"C23","span":{"begin":765,"end":784},"obj":"NP"},{"id":"C25","span":{"begin":807,"end":825},"obj":"NP"},{"id":"C24","span":{"begin":788,"end":825},"obj":"NP"},{"id":"C26","span":{"begin":861,"end":867},"obj":"NP"},{"id":"C27","span":{"begin":897,"end":930},"obj":"NP"},{"id":"C28","span":{"begin":985,"end":1004},"obj":"NP"},{"id":"C29","span":{"begin":1032,"end":1038},"obj":"NP"},{"id":"C30","span":{"begin":1040,"end":1055},"obj":"NP"},{"id":"C31","span":{"begin":1092,"end":1098},"obj":"NP"},{"id":"C32","span":{"begin":1126,"end":1143},"obj":"NP"},{"id":"C33","span":{"begin":1144,"end":1148},"obj":"NP"},{"id":"C34","span":{"begin":1153,"end":1159},"obj":"NP"},{"id":"C35","span":{"begin":1201,"end":1207},"obj":"NP"},{"id":"C36","span":{"begin":1218,"end":1233},"obj":"NP"},{"id":"C37","span":{"begin":1287,"end":1293},"obj":"NP"},{"id":"C38","span":{"begin":1350,"end":1365},"obj":"NP"},{"id":"C39","span":{"begin":1366,"end":1372},"obj":"NP"},{"id":"C41","span":{"begin":1500,"end":1506},"obj":"NP"},{"id":"C40","span":{"begin":1496,"end":1515},"obj":"NP"},{"id":"C43","span":{"begin":1592,"end":1596},"obj":"NP"},{"id":"C44","span":{"begin":1602,"end":1625},"obj":"NP"},{"id":"C42","span":{"begin":1565,"end":1625},"obj":"NP"},{"id":"C45","span":{"begin":1627,"end":1632},"obj":"NP"},{"id":"C47","span":{"begin":1680,"end":1686},"obj":"NP"},{"id":"C46","span":{"begin":1676,"end":1695},"obj":"NP"},{"id":"C48","span":{"begin":1711,"end":1717},"obj":"NP"},{"id":"C50","span":{"begin":1785,"end":1791},"obj":"NP"},{"id":"C49","span":{"begin":1781,"end":1800},"obj":"NP"},{"id":"C51","span":{"begin":1825,"end":1840},"obj":"NP"}],"relations":[{"id":"R1","pred":"coref-ident","subj":"C3","obj":"C2"},{"id":"R2","pred":"coref-ident","subj":"C5","obj":"C3"},{"id":"R3","pred":"coref-ident","subj":"C4","obj":"C1"},{"id":"R4","pred":"coref-relat","subj":"C7","obj":"C6"},{"id":"R5","pred":"coref-ident","subj":"C8","obj":"C5"},{"id":"R6","pred":"coref-relat","subj":"C10","obj":"C9"},{"id":"R7","pred":"coref-ident","subj":"C11","obj":"C8"},{"id":"R8","pred":"coref-ident","subj":"C14","obj":"C11"},{"id":"R9","pred":"coref-ident","subj":"C13","obj":"C4"},{"id":"R10","pred":"coref-other","subj":"C15","obj":"C12"},{"id":"R11","pred":"coref-relat","subj":"C16","obj":"C15"},{"id":"R12","pred":"coref-relat","subj":"C18","obj":"C15"},{"id":"R13","pred":"coref-other","subj":"C20","obj":"C12"},{"id":"R14","pred":"coref-ident","subj":"C25","obj":"C22"},{"id":"R15","pred":"coref-ident","subj":"C24","obj":"C21"},{"id":"R16","pred":"coref-ident","subj":"C26","obj":"C17"},{"id":"R17","pred":"coref-ident","subj":"C28","obj":"C23"},{"id":"R18","pred":"coref-ident","subj":"C29","obj":"C26"},{"id":"R19","pred":"coref-ident","subj":"C30","obj":"C28"},{"id":"R20","pred":"coref-ident","subj":"C31","obj":"C29"},{"id":"R21","pred":"coref-ident","subj":"C32","obj":"C25"},{"id":"R22","pred":"coref-relat","subj":"C33","obj":"C32"},{"id":"R23","pred":"coref-pron","subj":"C34","obj":"C32"},{"id":"R24","pred":"coref-ident","subj":"C35","obj":"C31"},{"id":"R25","pred":"coref-ident","subj":"C36","obj":"C30"},{"id":"R26","pred":"coref-ident","subj":"C37","obj":"C35"},{"id":"R27","pred":"coref-ident","subj":"C38","obj":"C36"},{"id":"R28","pred":"coref-pron","subj":"C39","obj":"C38"},{"id":"R29","pred":"coref-ident","subj":"C41","obj":"C14"},{"id":"R30","pred":"coref-ident","subj":"C40","obj":"C13"},{"id":"R31","pred":"coref-ident","subj":"C43","obj":"C19"},{"id":"R32","pred":"coref-ident","subj":"C44","obj":"C27"},{"id":"R33","pred":"coref-relat","subj":"C45","obj":"C42"},{"id":"R34","pred":"coref-ident","subj":"C47","obj":"C41"},{"id":"R35","pred":"coref-ident","subj":"C46","obj":"C40"},{"id":"R36","pred":"coref-ident","subj":"C48","obj":"C37"},{"id":"R37","pred":"coref-ident","subj":"C50","obj":"C47"},{"id":"R38","pred":"coref-ident","subj":"C49","obj":"C46"},{"id":"R39","pred":"coref-ident","subj":"C51","obj":"C38"}],"text":"Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.\nWe have conducted functional studies of the enhancer elements of human T-cell leukemia virus type I (HTLV-I) using the human T-cell lines Jurkat and MOLT 4, which are negative for HTLV-I, and MT-2 and TL-Mor, which carry the proviral genome of HTLV-I. Two distinct elements have been implicated in function of the HTLV-I enhancer. One is the 21-base-pair (bp) core element that is responsible for trans-activation by the HTLV-I trans-activator p40tax and that has the ability to bind to cyclic-AMP responsive element binding factor (CREB)-like factor(s). The other is a region interposed between the 21-bp elements. In this study we demonstrate that a subfragment (C26) in the region between the 21-bp elements is involved in trans-activation by p40tax, possibly through binding to an NF-kappa B-like nuclear factor or factors. Formation of the protein-DNA complex with the C26 subfragment was positively affected by p40tax. The C26 element conferred partial responsiveness to p40tax when linked to one copy of the 21-bp element that, by itself, showed little activation in response to p40tax. However, the C26 element alone, even when repeated, could not be activated by p40tax, unlike other NF-kappa B-binding elements. In contrast, the C26 element itself was profoundly activated upon stimulation with 12-O-tetradecanoylphorbol-13-acetate. These findings therefore suggest that the HTLV-I enhancer contains multiple functional elements, including binding sites for at least CREB- and NF-kappa B-like factors, which synergistically cooperate in activation of the HTLV-I enhancer in response to p40tax. Our results also demonstrate that TPA-dependent activation of the HTLV-I enhancer may be mediated through the C26 element."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":47,"end":62},"obj":"DNA_domain_or_region"},{"id":"T2","span":{"begin":88,"end":103},"obj":"protein_family_or_group"},{"id":"T3","span":{"begin":107,"end":113},"obj":"virus"},{"id":"T4","span":{"begin":159,"end":176},"obj":"DNA_domain_or_region"},{"id":"T5","span":{"begin":180,"end":214},"obj":"virus"},{"id":"T6","span":{"begin":216,"end":222},"obj":"virus"},{"id":"T7","span":{"begin":234,"end":252},"obj":"cell_line"},{"id":"T8","span":{"begin":253,"end":259},"obj":"cell_line"},{"id":"T9","span":{"begin":264,"end":270},"obj":"cell_line"},{"id":"T10","span":{"begin":295,"end":301},"obj":"virus"},{"id":"T11","span":{"begin":307,"end":311},"obj":"virus"},{"id":"T12","span":{"begin":316,"end":322},"obj":"virus"},{"id":"T13","span":{"begin":359,"end":365},"obj":"virus"},{"id":"T14","span":{"begin":429,"end":435},"obj":"virus"},{"id":"T15","span":{"begin":457,"end":487},"obj":"DNA_domain_or_region"},{"id":"T16","span":{"begin":512,"end":528},"obj":"other_name"},{"id":"T17","span":{"begin":536,"end":542},"obj":"virus"},{"id":"T18","span":{"begin":543,"end":558},"obj":"protein_family_or_group"},{"id":"T19","span":{"begin":559,"end":565},"obj":"protein_molecule"},{"id":"T20","span":{"begin":602,"end":646},"obj":"protein_molecule"},{"id":"T21","span":{"begin":648,"end":652},"obj":"protein_molecule"},{"id":"T22","span":{"begin":715,"end":729},"obj":"DNA_domain_or_region"},{"id":"T23","span":{"begin":811,"end":825},"obj":"DNA_domain_or_region"},{"id":"T24","span":{"begin":841,"end":857},"obj":"other_name"},{"id":"T25","span":{"begin":861,"end":867},"obj":"protein_molecule"},{"id":"T26","span":{"begin":900,"end":910},"obj":"protein_molecule"},{"id":"T27","span":{"begin":960,"end":979},"obj":"protein_complex"},{"id":"T28","span":{"begin":989,"end":1004},"obj":"protein_subunit"},{"id":"T29","span":{"begin":1032,"end":1038},"obj":"protein_molecule"},{"id":"T30","span":{"begin":1044,"end":1055},"obj":"DNA_domain_or_region"},{"id":"T31","span":{"begin":1092,"end":1098},"obj":"protein_molecule"},{"id":"T32","span":{"begin":1130,"end":1143},"obj":"DNA_domain_or_region"},{"id":"T33","span":{"begin":1201,"end":1207},"obj":"protein_molecule"},{"id":"T34","span":{"begin":1222,"end":1233},"obj":"DNA_domain_or_region"},{"id":"T35","span":{"begin":1287,"end":1293},"obj":"protein_molecule"},{"id":"T36","span":{"begin":1308,"end":1318},"obj":"protein_molecule"},{"id":"T37","span":{"begin":1354,"end":1365},"obj":"DNA_domain_or_region"},{"id":"T38","span":{"begin":1420,"end":1456},"obj":"other_organic_compound"},{"id":"T39","span":{"begin":1500,"end":1506},"obj":"virus"},{"id":"T40","span":{"begin":1525,"end":1553},"obj":"DNA_domain_or_region"},{"id":"T41","span":{"begin":1680,"end":1686},"obj":"virus"},{"id":"T42","span":{"begin":1711,"end":1717},"obj":"protein_molecule"},{"id":"T43","span":{"begin":1753,"end":1777},"obj":"other_name"},{"id":"T44","span":{"begin":1785,"end":1791},"obj":"virus"},{"id":"T45","span":{"begin":1829,"end":1840},"obj":"DNA_domain_or_region"}],"text":"Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.\nWe have conducted functional studies of the enhancer elements of human T-cell leukemia virus type I (HTLV-I) using the human T-cell lines Jurkat and MOLT 4, which are negative for HTLV-I, and MT-2 and TL-Mor, which carry the proviral genome of HTLV-I. Two distinct elements have been implicated in function of the HTLV-I enhancer. One is the 21-base-pair (bp) core element that is responsible for trans-activation by the HTLV-I trans-activator p40tax and that has the ability to bind to cyclic-AMP responsive element binding factor (CREB)-like factor(s). The other is a region interposed between the 21-bp elements. In this study we demonstrate that a subfragment (C26) in the region between the 21-bp elements is involved in trans-activation by p40tax, possibly through binding to an NF-kappa B-like nuclear factor or factors. Formation of the protein-DNA complex with the C26 subfragment was positively affected by p40tax. The C26 element conferred partial responsiveness to p40tax when linked to one copy of the 21-bp element that, by itself, showed little activation in response to p40tax. However, the C26 element alone, even when repeated, could not be activated by p40tax, unlike other NF-kappa B-binding elements. In contrast, the C26 element itself was profoundly activated upon stimulation with 12-O-tetradecanoylphorbol-13-acetate. These findings therefore suggest that the HTLV-I enhancer contains multiple functional elements, including binding sites for at least CREB- and NF-kappa B-like factors, which synergistically cooperate in activation of the HTLV-I enhancer in response to p40tax. Our results also demonstrate that TPA-dependent activation of the HTLV-I enhancer may be mediated through the C26 element."}